Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1198, pseudogene (RNU6-1198P) is an annotated genomic sequence homologous to U6 small nuclear RNA but lacks protein-coding or canonical functional activity[4][5]. U6 snRNA itself is a critical RNA component of the spliceosome, necessary for pre-mRNA splicing in eukaryotes[1][3]. Pseudogenes like RNU6-1198P are commonly found in the genome as evolutionary remnants of active snRNA genes, and they may exhibit high sequence similarity to the U6 snRNA but typically lack transcriptional activity or a direct cellular role[5]. Some pseudogenes can influence gene expression through regulatory mechanisms, but no specific evidence exists for regulatory or structural function for RNU6-1198P itself[2][5]. RNU6-1198P is not a conventional drug target, receptor, or effector molecule and should not be classified as such. It is a pseudogene without proven functional activity or clinical utility, and queries referencing it as a therapeutic target or receptor are considered incorrect in the context of direct drug discovery or targeted therapy[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1198, pseudogene (RNU6-1198P).